Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

MK-2206+Endocrine Therapy in Patients With Hormone Receptor-Positive Breast Cancer

This study has been withdrawn prior to enrollment.
(Funding not available, study did not open to accrual and will not open in future)
Sponsor:
Information provided by (Responsible Party):
Vandana Abramson, Vanderbilt-Ingram Cancer Center
ClinicalTrials.gov Identifier:
NCT01240928
First received: October 26, 2010
Last updated: August 18, 2013
Last verified: August 2013
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given